Established in 2019 with headquarter in Shanghai, Cutia is an R&D based start-up company mainly focusing on dermatology and aesthetics.
In 2020, Cutia started around ten clinical trials including all phases and most of them is operating on Viedoc's China server. The main reason of selecting Viedoc is that we believe it will bring us minimal setup time and maximal ease of use, a perfect match to the products study design in our pipelines.
- The team from Viedoc is efficient and we have the unimpeded communication. The quick response and professional advice impress us. We look forward to continuing the relationship with Viedoc in more fields in the future.
Chief Medical Officer, Cutia Therapeutics (Wuxi) Co., Ltd
"Excellent experience with the implementation of Viedoc's EDC"